Clinical characteristics and survival analysis of primary thyroid lymphoma
10.3760/cma.j.cn115355-20220725-00479
- VernacularTitle:原发甲状腺淋巴瘤临床特征及生存分析
- Author:
Zhiqiang ZHAO
1
;
Meng XING
;
Yu QIAO
;
Xuli YAN
;
Qinchuan YU
;
Likun ZAN
;
Liping SU
;
Lieyang WANG
Author Information
1. 山西省肿瘤医院 中国医学科学院肿瘤医院山西医院 山西医科大学附属肿瘤医院血液科，太原 030013
- Keywords:
Lymphoma;
Thyroid neoplasms;
Prognosis;
Clinical characteristics;
Survival analysis
- From:
Cancer Research and Clinic
2022;34(11):835-838
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical characteristics of primary thyroid lymphoma (PTL) and the differences in clinical manifestations and survival between the two main pathological subtypes of PTL.Methods:The clinical data of 52 patients with PTL diagnosed in Shanxi Province Cancer Hospital from January 2011 to January 2022 were retrospectively analyzed. The clinical characteristics and survival between the two main pathological subtypes [diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue lymphoma (MALT)] were compared.Results:Among 52 PTL patients, there were 12 males and 40 females, with a median age of 65 years old (34-83 years old). All patients presented with anterior cervical mass at the time of visit. MALT was diagnosed in 12 cases (23.1%). DLBCL was diagnosed in 37 cases (71.2%), of which 5 cases were double/triple expression lymphoma. B-cell lymphoma (unclassified) was diagnosed in 2 cases (3.8%). Follicular lymphoma (FL) was diagnosed in 1 case (1.9%). There was statistical difference in the proportion of patients with cervical lymph node enlargement between MALT and DLBCL patients [66.7% (8/12) vs. 94.6% (35/37), χ2 = 4.23, P < 0.05]. The 3-year OS rates of MALT and DLBCL patients were 90.9% and 73.9%, and the difference in OS between the two groups of patients was statistically significant ( χ2 = 5.11, P = 0.024). Conclusions:Pathological subtypes of PTL are related to the prognosis of patients.
